View examples of how we address the unique need of every research question to deliver innovative, multidimensional solutions to convey the value of healthcare innovations. Download our posters from recent conferences.
| Virtual ISPOR Europe 2020 Posters | Link |
|---|---|
| Treatment Sequencing in Modeling the Economic Benefits of Psoriasis Therapy- IMPACT of Key Assumptions | Download |
| Efficacy and Safety in Previously Untreated, Advanced/Metastatic Renal Cell Carcinoma – A Systematic Literature Review Update | Download |
| Overall Complete Remission Rate (OCRR) and Complete Remission Rate (CR) Of Standard of Care (SoC) In Relapsed/Refractory (R/R) Adult Acute Lymphoblastic Leukemia (aALL): A Meta-Analysis | Download |
| Real-World Effectiveness in Previously Untreated, Advanced/ Metastatic Renal Cell Carcinoma – A Systematic Literature Review Update | Download |
| Cost-Effectiveness Models and Resource Use/Cost Inputs for Untreated Advanced/Metastatic Renal Cell Carcinoma- A Systematic Literature Review | Download |
| Global Incidence, Prevalence, and Survival in Relapsed/Refractory (R/R) Adult Acute Lymphoblastic Leukemia (aALL): A Systematic Literature Review (SLR) | Download |
| Clinical Characteristics and Minimal Residual Disease (MRD) Testing Patterns in NEWLY Diagnosed Patients with B-CELL Precursor ACUTE Lymphoblastic Leukemia (ALL) from Italy: A Retrospective Chart Review | Download |
| Reported Utilities for Patients with Previously Untreated Advanced/ Metastatic Renal Cell Carcinoma – A Systematic Literature Review | Download |
| Updated Lifetime Survival Estimates for Nivolumab+ipilimumab in Previously Untreated Advanced/Metastatic Intermediate- or Poor-Risk Renal Cell Carcinoma (1L aRCC) | Download |
| Existing Health Economic Evaluations of Inflammatory Bowel Disease Show Important Methodological Limitations: A Targeted Literature Review | Download |
| Where Are We Headed with Digital Therapeutics? A Systematic Review of the Evidence | Download |
| Identifying Appropriate PROXY Diseases for Estimating LONG-TERM Survival and IMPACT on Health-Related Quality of Life of Patients with Aromatic L-Amino Acid Decarboxylase Deficiency (AADC-D) | Download |
| Estimating the LONG-TERM Effects of Therapy for Patients with Aromatic L-Amino Acid Decarboxylase Deficiency (AADC-D) Using Individual Participant DATA | Download |
| Synthesizing Evidence on Progression-Free Survival and Assessing The Feasibility of Network Meta-Analyses in Previously Untreated Advanced/Metastatic Renal Cell Carcinoma Therapies | Download |
| The Impact of Clinical Heterogeneity on Conducting Network MetaAnalyses for Overall Survival in Previously Untreated Intermediate- or Poor-Risk Advanced/Metastatic Renal Cell Carcinoma Therapies | Download |
| Synthesizing Evidence on Overall Survival and Assessing the Feasibility of Network Meta-Analyses in Previously Untreated Advanced/Metastatic Renal Cell Carcinoma Therapies | Download |
| The Impact of Clinical Heterogeneity on Conducting Network Meta-Analyses for Progression-Free Survival of Previously Untreated Intermediate- or Poor-Risk Advanced/Metastatic Renal Cell Carcinoma Therapies | Download |
| Systematic Identification of Potential Treatment Effect Modifiers in First Line Advanced Renal Cell Carcinoma | Download |
| Stroke and Bleeding Outcomes in Europe and ASIA in Patients with Nonvalvular Atrial Fibrillation Treated with NON-Vitamin K ORAL Anticoagulants (NOACS) in Real-Word Practice Renal Cell Carcinoma Therapies | Download |
| Economic and Humanistic Outcomes Associated with Treatment of Recurrent Ormetastatic Cervical Cancer: A Literature Review | Download |
| Budget Impact Analysis of Zanubrutinib for the Treatment of Adult Patients with Mantle Cell Lymphoma Who Have Received At Least One Prior Therapy From The Payer Perspective in the United States | Download |
| Patient Reported Outcomes Among Kte-X19 CAR T Treated Patients with Relapsed/Refractory Mantle Cell Lymphoma (R/R MCL) | Download |
| AMCP Nexus 2020 Virtual Conference Poster | Link |
|---|---|
| Burden of Parkinson’s Disease in a Real-World Sample of Patients with Motor Fluctuations | Download |
| Patient Characteristics, Treatment Patterns, Healthcare Resource Utilization, and Cost Associated with First-Line Therapies for Elderly Patients with Mantle Cell Lymphoma | Download |
| Real-World Incidence and Management of Adverse Events (AEs) in Patients with Non-Metastatic Castrate-Resistant Prostate Cancer Receiving Apalutamide or Enzalutamide | Download |
| 23rd International AIDS Conference Poster | Link |
|---|---|
| Comparative Efficacy and Safety of a Combination Therapy of Dolutegravir and Lamivudine VS 3-Drug Antiretroviral Regimens in Treatment-Naive HIV-1 Infected Patients at 96 Weeks: A Systematic Review and Network Meta-Analysis | Download |
| ISPOR 2020 Posters | Link |
|---|---|
| Humanistic Burden Associated with Depression and Anxiety Among Adults with Non-Communicable Chronic Diseases (NCCDs) in the United States | Download |
| Budget Impact Analysis of Introduction of Rituximab Biosimilar in the United States from a Payer Perspective | Download |
| Comparison of Treatment Adherence And Persistence with Edoxaban Versus Apixaban, Dabigatran, Rivaroxaban, and Vitamin K Antagonist in Non-Valvular Atrial Fibrillation Patients in Germany: A Propensity Matched Cohort Study | Download |
| Budget Impact Analysis of Introduction of Bevacizumab Biosimilar in the United States from a Payer Perspective | Download |
| Budget Impact Analysis of Introduction of IV Trastuzumab Biosimilar (Trastuzumab-qyyp) from Buyer and Payer Perspectives in France | Download |
| Real-World Economic and Clinical Outcomes Associated with Current Hemostatic Matrix Use in Spinal Surgery | Download |
| Real-World Economic and Clinical Outcomes Associated with Current Hemostatic Matrix Use in Cardiovascular Surgery | Download |
| ISPOR Europe Symposium | Link |
|---|---|
| SURVIVAL MODELLING: TRENDS AND INNOVATIONS | Download |
| ISPOR HEOR Theater | Link |
|---|---|
| COMMUNICATING VALUE TO DECISION-MAKERS: WHAT’S YOUR PROGNOSIS? | Download |
| ISPOR Europe 2019 Posters | Link |
|---|---|
| COST-EFFECTIVENESS OF NIVOLUMAB IN COMBINATION WITH IPILIMUMAB COMPARED TO SUNITINIB IN THE FIRST-LINE TREATMENT OF ADVANCED OR METASTATIC INTERMEDIATE- OR POOR-RISK RENAL CELL CARCINOMA IN ITALY | Download |
| COST-EFFECTIVENESS ANALYSIS OF NIVOLUMAB + IPILIMUMAB VERSUS SUNITINIB IN THE FIRST-LINE TREATMENT OF ADVANCED OR METASTATIC INTERMEDIATE- OR POOR-RISK RENAL CELL CARCINOMA IN SPAIN | Download |
| COST-EFFECTIVENESS OF NIVOLUMAB IN COMBINATION WITH IPILIMUMAB COMPARED TO SUNITINIB FOR THE FIRST-LINE TREATMENT OF ADVANCED/METASTATIC INTERMEDIATE- OR POOR-RISK RENAL CELL CARCINOMA IN SWITZERLAND | Download |
| UPDATED NETWORK META-ANALYSIS OF TREATMENTS IN FIRST-LINE ADVANCED/METASTATIC INTERMEDIATE- OR POOR-RISK RENAL CELL CARCINOMA | Download |
| STABILITY OF LIFETIME OVERALL SURVIVAL ESTIMATES OF NIVOLUMAB+IPILIMUMAB IN FIRST-LINE ADVANCED/METASTATIC INTERMEDIATE- OR POOR-RISK RENAL CELL CARCINOMA | Download |
| COST-EFFECTIVENESS ANALYSIS OF NIVOLUMAB IN COMBINATION WITH IPILIMUMAB FOR THE FIRST-LINE TREATMENT OF ADVANCED/METASTATIC RENAL CELL CARCINOMA IN GREECE | Download |
| COST-EFFECTIVENESS ANALYSIS OF NIVOLUMAB IN COMBINATION WITH IPILIMUMAB VERSUS SUNITINIB FOR THE FIRST-LINE TREATMENT OF INTERMEDIATE- TO POOR-RISK ADVANCED RENAL CELL CARCINOMA IN FRANCE | Download |
| USING MACHINE LEARNING FOR EFFICIENCY IMPROVEMENTS IN SYSTEMATIC LITERATURE REVIEWS OF CLINICAL EFFICACY AND SAFETY | Download |
| BAYESIAN MODEL AVERAGING FOR EXTRAPOLATING SURVIVAL: A PAN-TUMOR PERSPECTIVE ON NIVOLUMAB AND IPILIMUMAB | Download |
| MODELING THE SURVIVAL BENEFIT OF IMMUNO-ONCOLOGIC THERAPY: A REVIEW OF METHODS USED IN NICE SINGLE TECHNOLOGY APPRAISALS | Download |
| COMPARISON OF TIME TO REIMBURSEMENT RECOMMENDATIONS OF (ORPHAN-) ONCOLOGY DRUGS IN EUROPE | Download |
| MAXIMUM LIKELIHOOD ESTIMATION TO QUANTIFY THE IMPACT OF TREATMENT RESPONSE ON SURVIVAL OUTCOMES | Download |
| BALANCING GLOBAL HTA REQUIREMENTS FOR LITERATURE REVIEWS ACROSS EUROPE, NORTH AMERICA, AND ASIA | Download |
| IMPROVING THE ACCURACY AND REDUCING UNCERTAINTY OF PROBABILISTIC PARTITIONED SURVIVAL ANALYSES, BY CONSIDERING THE RELATIONSHIP BETWEEN PFS AND OS | Download |
| AMCP Nexus 2019 | Link |
|---|---|
| CHARACTERISTICS, SYSTEMIC TREATMENTS AND OUTCOMES IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA: A SYSTEMATIC LITERATURE REVIEW | Download |